Patents by Inventor Inder Jit SHARMA

Inder Jit SHARMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof
    Patent number: 11179453
    Abstract: An immunogenic composition comprising of Diphtheria toxoid antigen (D), tetanus toxoid (T) antigen, Hepatitis B surface antigen (HBsAg), inactivated whole-cell B. pertussis (wP) antigen, Haemophilus influenzae type B (Hib) capsular saccharide conjugated to a carrier protein, Inactivated Polio Virus (IPV) antigen and additionally one or more antigens and the method of preparing the same. A fully liquid combination vaccine, showing improved immunogenicity, reduced reactogenicity and improved stability. Improved methods of formaldehyde inactivation, improved adsorption profile of Diphtheria toxoid antigen (D), tetanus toxoid (T) antigen and Hepatitis B (HepB) surface antigen adsorbed individually onto aluminium phosphate adjuvant, minimum total aluminum content (Al3+) and optimized concentration of 2-phenoxyethanol (2-PE) as preservative.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: November 23, 2021
    Assignee: SERUM INSTITUTE OF INDIA PVT LTD
    Inventors: Rakesh Kumar, Inder Jit Sharma, Anil Vyankatrao Shitole, Manohar Doddapaneni, Hitt Jyoti Sharma
  • Combination Vaccine Composition Comprising Reduced Dose Inactivated Poliovirus And Method For Preparing The Same
    Publication number: 20210346483
    Abstract: The present disclosure relates to a fully liquid immunogenic composition comprising a combination of antigens/immunogens. The immunogenic composition comprises optimum amount of antigens/immunogens to confer protection against a number of diseases. The composition exhibits improved immunogenicity and stability. A process for preparing the vaccine composition is also disclosed.
    Type: Application
    Filed: October 4, 2019
    Publication date: November 11, 2021
    Inventors: Inder Jit SHARMA, Rakesh KUMAR, Jaganathan Semburakkiannan KILVANI, Manohar DODDAPANENI, Anil Vyankatrao SHITOLE
  • AN IMMUNOGENIC COMPOSITION HAVING IMPROVED STABILITY, ENHANCED IMMUNOGENICITY AND REDUCED REACTOGENICITY AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20200206331
    Abstract: An immunogenic composition comprising of Diphtheria toxoid antigen (D), tetanus toxoid (T) antigen, Hepatitis B surface antigen (HBsAg), inactivated whole-cell B. pertussis (wP) antigen, Haemophilus influenzae type B (Hib) capsular saccharide conjugated to a carrier protein, Inactivated Polio Virus (IPV) antigen and additionally one or more antigens and the method of preparing the same. A fully liquid combination vaccine, showing improved immunogenicity, reduced reactogenicity and improved stability. Improved methods of formaldehyde inactivation, improved adsorption profile of Diphtheria toxoid antigen (D), tetanus toxoid (T) antigen and Hepatitis B (HepB) surface antigen adsorbed individually onto aluminium phosphate adjuvant, minimum total aluminum content (Al3+) and optimized concentration of 2-phenoxyethanol (2-PE) as preservative.
    Type: Application
    Filed: July 13, 2018
    Publication date: July 2, 2020
    Inventors: Rakesh KUMAR, Inder Jit SHARMA, Anil Vyankatrao SHITOLE, Manohar DODDAPANENI, Hitt Jyoti SHARMA